By Boris Goldstein, Co-Founder & Executive Chairman at Brain Scientific COVID-19 is known for its impacts on a patient’s respiratory system, but it has also been found to affect individuals in unique ways and with varying severity levels depending on their age, risk factors, and comorbidities. Several studies have recently shown that the development of neurological conditions and symptoms are prevalent in COVID patients. Neurologic manifestations, including headaches, myalgias, dizziness, and encephalopathy, occur in most hospitalized COVID-19 patients. According to a recent study published in Annals of Clinical and Translational Neurology, 42% of these symptoms were present at the onset,
The post Neurology’s Growing Need for Disposable Technologies appeared first on Pharma Mirror Magazine.
